Can a smarter glucose monitor stop dangerous lows? small study tests predictive alerts

NCT ID NCT07614139

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This completed study tested whether a continuous glucose monitor with predictive alerts (Dexcom G7) can reduce low blood sugar better than a standard alert monitor (Dexcom ONE+) in 11 adults with glycogen storage disease or congenital hyperinsulinism. Participants wore each device for 30 days, checked blood sugar, and filled out questionnaires. The goal was to see if early warnings help prevent hypoglycemia and improve quality of life.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Continuous glucose monitor (Dexcom G7 and Dexcom ONE+)
What this could lead to
If predictive alerts work better, this could help people with metabolic disorders avoid dangerous low blood sugar episodes and improve daily life.
What could go wrong
This was a very small study (11 people) and only looked at short-term use. Results may not apply to everyone, and the device may not be accurate for all users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL HYPERINSULINISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital of Padova

    Padova, Padova, 35128, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.